| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.09 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.095 | 0.1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.085 | 0.1 |